Home > Drug Search >
  • company_query: Abgenix
  •   > 
Drug Filter
Category:
chemistry (4) biology (30)
Status:
Approved (5) BLA Filing (1) Phase Ⅲ (5) Phase Ⅱ (10) Phase Ⅰ (10) IND Filing (3)
Clinical Stage:
Pending (1) Active (21) Discontinued (7)
Bio-Type:
Gene therapy (1) Vaccine (7) Recombinant cytokines (6) Other recombinant protein (1) Whole antibody (9) ADC (1) Fusion protein (1)
Indication:
Anemia (2) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (1) Candidiasis (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Coronary artery disease (CAD) (1) Epilepsy/Seizures (1) Idiopathic pulmonary fibrosis (IPF) (1) Inflammatory bowel disease (1) Influenza virus infection (2) Melanoma (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (3) Myelofibrosis (1) Myocardial infarction (MI) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin’s lymphoma (NHL) (1) Osteoarthritis (OA) (1) Postmenopausal osteoporosis (1) Measles (1) Mumps (1) Rubella (1) Prostate cancer (2) Psoriasis (1) Rheumatoid arthritis (RA) (5) Solid tumours (1) Systemic lupus erythematosus (1) Colorectal cancer (1) Pain (1) Anesthesia (1) Bone metastases from solid tumors (1) HER2-positive metastatic breast cancer (1) Malaria (2) Neutropenia (1) Lupus nephritis (1) Thrombosis (1) Skin hypertrophic scars (1) HER2-positive breast cancer (1) Giant cell tumor of bone (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top